These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 25209056

  • 1. Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.
    Penn DC, Chang Y, Meyer AM, DeFilippo Mack C, Sanoff HK, Stitzenberg KB, Carpenter WR.
    Cancer; 2015 Jan 01; 121(1):93-101. PubMed ID: 25209056
    [Abstract] [Full Text] [Related]

  • 2. Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults.
    Mack CD, Carpenter W, Meyer AM, Sanoff H, Stürmer T.
    Cancer; 2012 Jun 01; 118(11):2925-34. PubMed ID: 22072441
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer.
    Panchal JM, Lairson DR, Chan W, Du XL.
    Clin Colorectal Cancer; 2013 Jun 01; 12(2):113-21. PubMed ID: 23137529
    [Abstract] [Full Text] [Related]

  • 5. Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer.
    Tan HJ, Meyer AM, Kuo TM, Smith AB, Wheeler SB, Carpenter WR, Nielsen ME.
    Cancer; 2015 Mar 15; 121(6):836-43. PubMed ID: 25410684
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lack of access to chemotherapy for colon cancer: multiplicative disadvantage of being extremely poor, inadequately insured and African American.
    Gorey KM, Haji-Jama S, Bartfay E, Luginaah IN, Wright FC, Kanjeekal SM.
    BMC Health Serv Res; 2014 Mar 22; 14():133. PubMed ID: 24655931
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A method for analyzing the business case for provider participation in the National Cancer Institute's Community Clinical Oncology Program and similar federally funded, provider-based research networks.
    Reiter KL, Song PH, Minasian L, Good M, Weiner BJ, McAlearney AS.
    Cancer; 2012 Sep 01; 118(17):4253-61. PubMed ID: 22213241
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential receipt of sentinel lymph node biopsy within practice-based research networks.
    Meyer AM, Reeder-Hayes KE, Liu H, Wheeler SB, Penn D, Weiner BJ, Carpenter WR.
    Med Care; 2013 Sep 01; 51(9):812-8. PubMed ID: 23942221
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.